Related Experiment Video
Updated: Sep 20, 2026

Measuring Global Cellular Matrix Metalloproteinase and Metabolic Activity in 3D Hydrogels
Published on: January 22, 2019
Inhibitory effect of green tea polyphenols on membrane-type 1 matrix metalloproteinase, MT1-MMP
Naoto Oku1, Motomi Matsukawa, Satoru Yamakawa
1Department of Medical Biochemistry and COE Program in the 21st Century, University of Shizuoka, School of Pharmaceutical Sciences.
Abstract:
Matrix metalloproteinases (MMPs), especially membrane-type 1 matrix metalloproteinase (MT1-MMP), which generates an active form of MMP-2 from proMMP-2, are deeply involved in angiogenesis as well as in tumor cell migration and metastasis. To obtain a specific inhibitor for MT1-MMP, we screened a number of natural and synthetic compounds using recombinant human MMP-2, MMP-7, and soluble MT1-MMP in a fluorogenic peptide cleavage assay. (-)-Epigallocatechin 3-O-gallate (EGCG) followed by (-)-epigallocatechin 3,5-di-O-gallate and epitheaflagallin 3-O-gallate, was found to have potent and distinct inhibitory activity against MT1-MMP. Therefore, we investigated the effect of EGCG on the suppression of MMP-2 activation as determined by gelatin zymography, and observed that the active form of MMP-2 in the conditioned medium of human umbilical vein endothelial cells was decreased in the presence of EGCG. The results suggest the possibility that tea polyphenols suppress tumor growth through the suppression of angiogenesis.
Insights
(-)-Epigallocatechin 3-O-gallate (EGCG), a tea polyphenol, potently inhibits membrane-type 1 matrix metalloproteinase (MT1-MMP). This inhibition suppresses the activation of MMP-2, potentially hindering tumor growth and angiogenesis.
Area of Science:
- Biochemistry
- Molecular Biology
- Cancer Research
Background:
- Matrix metalloproteinases (MMPs), particularly MT1-MMP, play crucial roles in angiogenesis, tumor cell migration, and metastasis.
- MT1-MMP is responsible for activating MMP-2, a key enzyme in extracellular matrix remodeling.
Purpose of the Study:
- To identify specific inhibitors of MT1-MMP from natural and synthetic compounds.
- To investigate the anti-angiogenic and anti-metastatic potential of identified inhibitors.
Main Methods:
- Screening of natural and synthetic compounds using recombinant human MMP-2, MMP-7, and soluble MT1-MMP in a fluorogenic peptide cleavage assay.
- Assessing the inhibitory activity of compounds against MT1-MMP.
- Evaluating the effect of EGCG on MMP-2 activation in human umbilical vein endothelial cells using gelatin zymography.
Main Results:
- (-)-Epigallocatechin 3-O-gallate (EGCG) demonstrated potent and specific inhibitory activity against MT1-MMP.
- EGCG also inhibited the activation of MMP-2 in human umbilical vein endothelial cells.
- Other related tea polyphenols, such as (-)-epigallocatechin 3,5-di-O-gallate and epitheaflagallin 3-O-gallate, showed inhibitory effects.
Conclusions:
- EGCG is a potent inhibitor of MT1-MMP and suppresses MMP-2 activation.
- Tea polyphenols, like EGCG, may suppress tumor growth by inhibiting angiogenesis.
- These findings highlight the potential of EGCG as a therapeutic agent targeting MT1-MMP in cancer treatment.
